Your source for all Prime Therapeutics' June 2026 Drug Insights publications.

Prime Therapeutics (Prime) provides you with regular updates on the drug pipeline as well as next-generation clinical information and hot topics. The following Drug Insights publications for June 2026 will keep you informed on what’s trending now and trending clinical topics. 

---

Released June 15, 2026

FDA Decisions Expected: July 2026

A breakdown of FDA decisions expected of new drugs anticipated to hit the market, this edition covers brepocitinib, denecimig and more.

---

Released June 23, 2026

Cell & Gene Pipeline Outlook: June 2026

Our newest publication tracks what is ahead in the cell and gene therapy (CGT) pipeline over the next few years. Check out our latest edition for insights on cell therapies and gene therpies poised for growth. 

---

Released June 30, 2026

Trending Topics & Drug Approvals: June 2026

Prime covers hot topics and the latest specialty and traditional drug approvals. The latest edition covers findings from double-blind, placebo-controlled Phase 3b trials for weight loss. 

---

Released July 2, 2026

Oncology Insights

Featuring commentary by Abby Kim, PharmD, BCOP, on developments in the oncology space, this installment reviews key takeaways from the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and what they mean for payers.

---

Looking for previous 2026 drug insights publications?

Simply click on the month to access past editions of our drug insights.

January 2026
February 2026
March 2026
April 2026
May 2026